Today, the Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released a new report on the best practices in state bioscience economic development measures, “The U.S. Biosciences Industry in the States: Best Practices in Innovation, Partnerships, and Job Creation.”Continue reading→

Two bills to create a healthy investment environment for biotech startups passed the House late May 30 with overwhelming bipartisan support. The legislation was also supported by the Biotechnology Innovation Organization (BIO).
Continue reading→

New research released by Vital Transformation (VT) shows that the Inflation Reduction Act (IRA) will stifle the ability of companies to continue research and development across a broad range of therapeutic areas. The effects of the IRA will have a far more serious impact on the development of new medicines than has been reported, according to the research.Continue reading→

Impact of the IRA on Oncology Patient Care features an interview with Dr. Barbara L. McAneny, MD, FASCO, MACP Former President for the American Medical Association and the New Mexico Medical Society (NMMS); and currently CEO, New Mexico Cancer Center.

With Dr. Steve Potts CEO, Anticipate Bioscience.

Impact of the IRA on Oncology Patient Care was recorded on the 26th of May 2023Continue reading→

Arizona Gov. Katie Hobbs  has signed Arizona’s FY24 budget.  The state’s $17.8 billion spending plan includes money to prevent homelessness, boost education funding and send tax rebates to parents.  It also includes some interesting and,  in some cases,  surprising additions or omissions. Continue reading→

Grass roots advocacy is when people engage in the legislative process by sharing their views with their elected leaders.  It can take the form of writing or signing on to letters, testifying at hearings, attending town halls, visiting an elected leader at their office; or, here in Arizona, sharing their position on bills at the Legislature using the Request to Speak System. Continue reading→

The Arizona Health Innovation Trust Fund (AHIT) was established in 2022 to develop workforce programs; support small health innovation businesses; and provide other financial support that will drive growth in Arizona’s life science sector. On February 23, 2023, SB1084 was amended to appropriate $50 million in funding for AHIT in Arizona’s FY24 budget and declares that the Legislature intends that the Fund steadily grows to maintain a permanent endowment balance of at least $200 million. The amended bill received a Do Pass as Amended recommendation.  SB1084 now moves to consideration by the Senate Rules Committee.Continue reading→

 On February 23,2023, the Arizona Senate Appropriations gave a Do Pass Recommendation to SB1562 which updates and expands Arizona’s R&D Tax Credit program.Continue reading→

Established in 2022, the Arizona Health Innovation Trust Fund (AHIT) is designed to help Arizona become home to a top-ten life science sector by helping to bridge the “valley of death.” During the 2023 legislative session, our elected leaders have the opportunity to make the investment that will capitalize the AHIT. Continue reading→

In 2022, Arizona established the Arizona Health Innovation Trust Fund as a vehicle to drive the creation of health innovations that can improve quality of life for people of Arizona and increase opportunities for the high quality jobs Arizona Health Innovators create.  The FY2023 appropriation was $100,000 to allow the initial set up of the fund.  In 2023, two bills at the Arizona Legislature (HB2253 and SB1084) propose a $200 million dollar one-time investment into the Arizona Health Innovation Trust Fund.Continue reading→